In particular p15INK4b and p16INK4a expression is increased in non-RET sporadic and RET-mutated, hereditary MTCs while p18INK4c and p19INK4d levels are elevated in non-RET sporadic MTC only. This evidence concerns the gene CDKN2A and medullary thyroid gland carcinoma.